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Background:TGF receptor signals through Smad phosphorylation, which is dependent on endocytosis of TGF receptors
and the Smad anchor protein SARA localized on endosomes.
Results: Class II PI3K-C2 is necessary for TGF receptor endocytosis into SARA-containing endosomes, SARA-Smad com-
plex formation, and Smad phosphorylation.
Conclusion: PI3K-C2 serves endosomal TGF receptor signaling.
Significance: PI3K-C2 is a key molecule that is generally engaged in endosomal receptor signaling.
We have recently demonstrated that the PI3K class II- iso-
form (PI3K-C2), which generates phosphatidylinositol 3-
phosphate and phosphatidylinositol 3,4-bisphosphates, plays
crucial roles in angiogenesis, by analyzing PI3K-C2 knock-out
mice. The PI3K-C2 actions are mediated at least in part
through its participation in the internalization of VEGF recep-
tor-2 and sphingosine-1-phosphate receptor S1P1 and thereby
their signaling on endosomes. TGF, which is also an essential
angiogenic factor, signals via the serine/threonine kinase recep-
tor complex to induce phosphorylation of Smad2 and Smad3
(Smad2/3). SARA (Smad anchor for receptor activation) pro-
tein, which is localized in early endosomes through its FYVE
domain, is required for Smad2/3 signaling. In the present study,
we showed that PI3K-C2 knockdown nearly completely abol-
ished TGF1-induced phosphorylation and nuclear transloca-
tion of Smad2/3 in vascular endothelial cells (ECs). PI3K-C2
was necessary for TGF-induced increase in phosphatidylinosi-
tol 3,4-bisphosphates in the plasma membrane and TGF
receptor internalization into the SARA-containing early endo-
somes, but not for phosphatidylinositol 3-phosphate enrich-
ment or localization of SARA in the early endosomes. PI3K-C2
was also required for TGF receptor-mediated formation of
SARA-Smad2/3 complex. Inhibition of dynamin, which is
required for the clathrin-dependent receptor endocytosis, sup-
pressed bothTGF receptor internalization and Smad2/3 phos-
phorylation. TGF1 stimulated Smad-dependent VEGF-A
expression, VEGF receptor-mediated EC migration, and capil-
lary-like tube formation, which were all abolished by either
PI3K-C2 knockdown or a dynamin inhibitor. Finally, TGF1-
induced microvessel formation in Matrigel plugs was greatly
attenuated in EC-specific PI3K-C2-deletedmice. These obser-
vations indicate that PI3K-C2 plays the pivotal role in TGF
receptor endocytosis and thereby Smad2/3 signaling, partici-
pating in angiogenic actions of TGF.
PI3Ks are a family of enzymes that phosphorylatemembrane
inositol phospholipids at the 3 position of the inositol ring and
comprise three classes (classes I–III) (1, 2). Class I PI3Ks, which
mainly generate phosphatidylinositol 3,4,5-bisphosphates, are
activated by receptor tyrosine kinases and G protein-coupled
receptors to mediate activation of Akt and Rac, stimulating cell
proliferation and migration. In contrast to the well character-
ized class I PI3Ks, physiological roles of class II PI3Ks, which
have three members: PI3K-C2, PI3K-C2, and PI3K-C2,
were not well understood (3–7).We have recently revealed that
PI3K-C2 plays a crucial role in angiogenesis andmaintenance
of the endothelial barrier integrity in an endothelial cell (EC)2
autonomous manner (8). PI3K-C2 is localized in clathrin-
coated pits and endocytic vesicles, early endosomes, and the
trans-Golgi network (8–11) and is thought to predominantly
generate phosphatidylinositol 3-phosphate (PtdIns(3)P) and/or
phosphatidylinositol 3,4-bisphosphates (PtdIns(3,4)P2) in vivo
differently from class I PI3K (3–5, 7, 12–14). Our data showed
that PI3K-C2 regulates vesicular trafficking in EC and thereby
is indispensable for vesicular transport-mediated delivery of
cargos including the endothelial adhesion molecule VE-cad-
herin and ligand binding-induced endocytosis of the receptor
tyrosine kinase VEGF receptor-2 (VEGFR2) and the G protein-
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coupled receptor S1P1 (8, 15, 16). Signaling of VEGFR2 and
S1P1 was defective in PI3K-C2-depleted EC: the receptor
endocytosis was inhibited, and the signaling on endosomes,
particularly Rho GTPase activation, was impaired. These
defects result in impairedmigration, proliferation, and intercel-
lular junction formation in EC. It is unknownwhether and how
PI3K-C2 regulates signaling of other angiogenic receptors. In
addition to our studies, a general regulatory role for PI3K-C2
in endocytosis through the generation of PtdIns(3,4)P2 in the
plasma membrane was recently reported (14).
TGF is involved in the regulation of migration and prolifer-
ation of EC, production of basement membrane, and differen-
tiation and recruitment of mural cells, thus being essential for
normal vascular formation (17–20). TGF signals through type
I and type II TGF receptors, which are both serine/threonine
transmembrane kinases (21–23). TGF binds to type II recep-
tor, which phosphorylates and activates type I receptors, activin
receptor-like kinase (ALK) 1, and ALK5. ALK1 and ALK5 in
turn phosphorylate the receptor-regulated Smads, Smad1
and Smad5 (Smad1/5) and Smad2 and Smad3 (Smad2/3),
respectively. Phosphorylated receptor-regulated Smads form
complexes with the common mediator Smad4 and the Smad
complexes translocate into the nucleus to regulate gene tran-
scription. It was proposed that TGF signaling pathways via
ALK1 andALK5 in ECmay play a balancing role for controlling
proliferation and migration of EC during angiogenesis (24, 25).
Of the twoTGF signaling pathways, EC-specific gene ablation
of either ALK5 or Smad2/3 resulted in the similar vascular
abnormalities, indicating a pivotal role of endothelial ALK5-
Smad2/3 pathway in the angiogenic effect of TGF (19, 20, 26,
27). SARA (Smad anchor for receptor activation) protein con-
tains the binding domains for both Smad2/3 and the TGF
receptor complex and is localized in the early endosomes
through its FYVE domain, which specifically recognizes and
binds to PtdIns(3)P (28). Previous studies (28–31) demon-
strated that upon TGF stimulation, the TGF receptor com-
plex undergoes clathrin-dependent endocytosis into the early
endosomes containing SARA and that the proper localization
of SARA in the early endosomes and the TGF receptor inter-
nalization into the SARA-containing endosomes are the events
necessary for TGF-induced phosphorylation of Smad2/3 and
the following nuclear translocation of the Smad complexes. It is
likely that PI3Ks are involved in TGF receptor internalization,
the endosomal localization of SARA, and thus TGF signaling.
However, it is unknownwhich isoformof PI3K is engaged in the
processes of TGF signaling.
In the present study, we studied a role for PI3K-C2 in
TGF-induced Smad2/3 signaling in EC.We found that TGF-
induced Smad2/3 phosphorylation, Smad2/3-dependent gene
expression, and angiogenic responses were strongly dependent
onPI3K-C2. PI3K-C2was required forTGF receptor inter-
nalization but not the endosomal localization of SARA. These
observations suggest that PI3K-C2 plays an indispensable role
in endosomal TGF receptor signaling.
EXPERIMENTAL PROCEDURES
Cells—Human umbilical vein endothelial cells (HUVECs)
(Lonza, Basel, Switzerland), the humanmicrovascular endothe-
lial cells (HMVECs), and mouse lung vascular endothelial cells
(MLECs)were plated onto type I collagen (NittaGelatin,Osaka,
Japan)-coated dishes and flasks and allowed to grow under 5%
CO2 at 37 °C in complete endothelial growth medium contain-
ing 2%FBS and growth factor supplements (EGM-2 (catalog no.
CC3156; Lonza) for HUVECs and EBM-2-MV (catalog no.
CC4147; Lonza) for HMVECs and MLECs). HUVECs between
passages 4 and 6 were used for all experiments. MLECs and
mouse aortic smooth muscle (MASM) cells were isolated from
Pik3c2aflox/flox mice and used for in vitro assays as described
previously (8, 32, 33). HEK293T cells, MASM cells, and Caco2
cells were cultured in 10% FBS (Invitrogen Gibco)-supple-
mentedDMEM forHEK293T andCaco2 cells (catalog no. 041-
29775; Invitrogen Gibco) and advanced DMEM for MASM
cells (catalog no. 12491; Invitrogen Gibco).
Small Interfering RNA, Plasmids, and Transfection—Knock-
down of endogenous PI3K isoforms and Smad4 were per-
formedwith the siRNAs that were synthesized using a Silencers
siRNA construction kit (catalog no. AM1620; Ambion, Austin,
TX) according to the manufacturer’s instructions. The target
sequences were: 5-AAGGTTGGCACTTACAAGAAT-3 and
5-AAGTAAGCCTAAGGTGGATAA-3 for human PI3K-
C2 #1 and #2, respectively; 5-AAGCCGGAAGCTTCTGG-
GTTT-3 for PI3K-C2; 5–GGACAACTGTTTCATA-
TAG-3 for class I PI3K p110; 5-AAACTCAACACTGGCT-
AATTA-3 for Vps34; 5-AATACATTCCAACTGCACA-
CCC-3 for Smad4; and 5-GGGGGAAATACGACTTAGTG-
AGG-3 for ALK5. HUVECs were transfected by incubating
with the siRNAs in the presence of Lipofectamine 2000 (catalog
no. 11668-019; Invitrogen) for 48–72 h before the experiments.
MASM cells isolated from Pik3c2aflox/flox mice were grown to
70% confluency and then infected with the adenovirus encod-
ing Cre recombinase (Ad-Cre) in the absence of serum.
Adenovirus encoding LacZ (Ad-LacZ) was used as control.
After 1 h of adenovirus infection, the growth medium containing
10% FBS was added, and the cells were allowed to recover for the
next48h.Theexpressionvector forGFP-PI3K-C2wasdescribed
previously (8). The expression vectors for the PI3K-C2-specific
siRNA-resistant form of PI3K-C2 (C2r) and the kinase-defi-
cient mutant (D1268A) of GFP-PI3K-C2 (GFP-kdPI3K-
C2) were generated using a standard PCR-basedmethod (34). In
C2r, the codons AAG-GTT-GGC-ACT-TAC for the amino
acids Lys728-Val729-Gly730-Thr731-Tyr732 were replaced by the
nucleotides AAA-GTC-GGT-ACC-TAT, which encodes the
same amino acids. The changes in these nucleotides rendered
C2r resistant to the PI3K-C2-specific siRNA. The expression
vectors for FLAG-tagged wild-type SARA (wtSARA), FLAG-
tagged Smad-binding domain (the amino acids 665–704)-deleted
SARA mutant (SBD-SARA), FLAG-tagged wild-type ALK5
(wtALK5), FLAG-tagged constitutively activatedmutant (T202D)
of ALK5 (caALK5), and GFP-PHTAPP1 were purchased from
Addgene (Cambridge, MA). The expression vector for GFP-
FYVESARA was provided by Dr. S. Itoh (Showa Pharmaceutical
University) (26). The expression vectors for FLAG-tagged Smad2
and FLAG-tagged Smad3 were provided by Dr. K. Miyazono
(University of Tokyo) (35).
Immunoblotting and Immunoprecipitation Analysis—At
48 h after siRNA transfection, the cells were serum-starved
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with M199 (Invitrogen Gibco) containing 0.5% fatty acid-free
BSA (catalog no. A6003; Sigma-Aldrich) for 4 h and then stim-
ulated with 5 ng/ml TGF1 (catalog no. 240-B; R&D Systems,
Minneapolis, MN). The cells were washed in PBS and lysed in
the cell lysis buffer (20 mM Tris-HCl, pH 7.2, 150 mM NaCl, 1
mM CaCl2, 0.5% Triton X-100, 100 mM NaF, 1 mM Na3VO4)
supplemented with Complete Protease inhibitor mixture
(Roche Applied Science) by scraping, followed by centrifuga-
tion for 15min at 16, 000 g at 4 °C.The resultant supernatants
were taken, electrophoresed on 8% SDS-PAGE, and transferred
onto PVDF membrane (Millipore, Billerica, MA). The mem-
branes were blocked in PBS containing 5% BSA and incubated
with respective antibodies overnight. The antibodies used are
PI3K-C2 (catalog no. 611046; BD Biosciences, San Jose, CA),
PI3K-C2 (catalog no. 611342; BDBiosciences), p110 (catalog
no. 4249; Cell Signaling, Danvers, MA), Vps34 (catalog no.
4263; Cell Signaling), total Smad2/3 (catalog no. 610842; BD
Biosciences), phosphorylated Smad2 (p-Smad2) (catalog no.
3101; Cell Signaling), phosphorylated Smad3 (p-Smad3) (cata-
log no. 9520; Cell Signaling), total ERK1/2 (catalog no. 9102;
Cell Signaling), phosphorylated ERK1/2 (catalog no. 4370; Cell
Signaling), total Smad4 (catalog no. 9515; Cell Signaling); SARA
(catalog no. sc-9135; Santa Cruz, Dallas, TX), phosphoserine
(catalog no. 618100; Invitrogen), and -actin (catalog no.
A1978; Sigma-Aldrich). The membranes were incubated with
alkaline phosphatase-conjugated secondary antibodies (anti-
mouse IgG antibody, catalog no. 7056; anti-rabbit IgG anti-
body, catalog no. 7054) (Cell Signaling) and visualized by color
reaction using 5-bromo-4-chloro-3-indolyl-phosphate/nitro
blue tetrazolium (Wako, Osaka, Japan). The band intensities
were determined using Image Gauge (Fuji Film, Tokyo, Japan).
The values were normalized for the value of-actin as a loading
control and expressed as multiples over the normalized values
of untreated controls.
For immunoprecipitation assay, HEK293T cells were co-
transfected with the expression vectors for FLAG-Smad3,
either FLAG-SARA or FLAG-SBD-SARA, and either FLAG-
wtALK5 or FLAG-constitutively activated ALK5 (caALK5) and
72 h later were lysed in IP buffer (50 mM Tris-HCl, pH 7.5, 150
mMNaCl, 1%Nonidet P-40, 0.5% deoxycholate, 0.1% SDS) sup-
plemented with Complete Protease inhibitor cocktails. The
lysates were incubated with anti-SARA antibody for 1 h at 4 °C
with rocking, followed by the incubation with protein G-aga-
rose beads (catalog no. 1-719-416; Roche) for 1 h at 4 °C. After
the beads were washed five times, they were mixed with 2
Laemmli’s SDS sample buffer and boiled. The resultant sam-
ples were analyzed with immunoblotting using respective
antibodies.
Immunohistochemistry and Immunofluorescence Staining—
HUVECs were plated onto type I collagen-coated glass bottom
dishes (MatTek Corporation, Ashland, MA) and allowed to
adhere to dishes in EGM-2 growthmediumovernight. The cells
were rinsed with prewarmed PBS once and fixed in prewarmed
4% fresh paraformaldehyde in PBS for 10 min, washed with
PBS, and then permeabilized in 0.2%TritonX-100 in PBS for 15
min when necessary. After the cells were incubated with 5%
normal goat serum for 60 min to inhibit nonspecific protein
binding, the cells were incubated with rabbit polyclonal anti-p-
Smad2 antibody (catalog no. AB3849;Millipore),mousemono-
clonal anti-Smad2/3 antibody (catalog no. 610842; BD Biosci-
ences), rabbit polyclonal anti-SARA antibody, or mouse
monoclonal anti-EEA1 antibody (catalog no. 610456; BD Bio-
sciences) for 2 h at room temperature or overnight at 4 °C. The
cellswere incubated for 60min at room temperaturewithAlexa
Fluor 488-conjugated goat anti-mouse (catalog no. A31620;
Molecular Probes), Alexa Fluor 488-conjugated goat anti-rab-
bit (catalog no. A11034), Alexa Fluor 594-conjugated goat anti-
mouse (catalog no. A31624), Alexa Fluor 594-conjugated goat
anti-rabbit (catalog no. A31620), and secondary antibodies
diluted at 1:1000 in PBS. Where appropriate, the cells were
counterstained with DAPI (catalog no. D1306;Molecular Probes)
for 5 min. The cells were mounted on Fluoromount (catalog no.
K024; Diagnostic BioSystems, Pleasanton, CA) and observed
under a custom confocal microscope unit as described in detail
previously (8). For immunohistochemistry of the sections of
Matrigel plugs, the sections of paraformaldehyde-fixed, paraffin-
embedded Matrigel plug were deparaffinized and processed in
heat-induced target retrieval to unmask the antigen using with
target retrieval solution (Dako,Carpinteria,CA) (30).The sections
were incubated with Dako blocking solution (catalog no. X0909;
Dako) for 10 min to inhibit nonspecific protein binding. After
blocking, the sectionswere stainedwith rabbit polyclonal anti-von
Willebrand factor (vWF) (catalog no. A0082; Dako) for 60 min at
room temperature. The sections were incubatedwith the second-
ary antibody of an EnVision kit (catalog no. K4002; Dako) for 60
min,andthecolor reactionwasdeveloped.Whereappropriate, the
sectionswerecounterstainedwithhematoxylin.Thesectionswere
examined using a BX41 inverted microscope (Olympus, Tokyo,
Japan), and vWF-positive microvessel numbers were determined
with ImageJ software.
Proximity Ligation Assay (PLA) Staining—The cells were
fixed in prewarmed 4% fresh paraformaldehyde in PBS for 10
min and permeabilized in 0.2% Triton X-100 in PBS for 15 min
whennecessary. After the cellswere incubatedwith rabbit poly-
clonal anti-ALK5 antibody (catalog no. sc-398; Santa Cruz),
mouse monoclonal anti-Smad2/3 antibody, and mouse mono-
clonal anti-SARA (catalog no. sc-133071; Santa Cruz) antibody
overnight at 4 °C, in situ protein interactions were detected
using the Duolink proximity ligation assay kit according to the
manufacturer’s instructions (Olink Bioscience, Uppsala, Swe-
den). The cells were stained with anti-EEA1-Alexa Fluor 594
(M176 A59; MBL, Nagoya, Japan).
RNA Isolation and Quantitative PCR Analysis—Total RNA
in HUVECs was isolated using TRIzol reagent (Invitrogen). One
g of total RNA was reverse-transcribed into the first strand
cDNA using QuantiTect RT Kit (catalog no. 205311; Qiagen).
Quantitative real time PCRs were performed using FAM-conju-
gated TaqMan inventoried assay from Applied Biosystems
for human PI3K-C2 (Hs0090461_m1) and human VEGF-A
(Hs00900055_m1). 18 S rRNA (Hs99999901_s1) probe was used
as an internal control. ThemRNA expression levels were normal-
ized for the expression of 18 S rRNAmRNA, and the results were
expressed asmultiples over control values. Comparative quantita-
tive analysis was performed using the GeneAmp 7300 system
(AppliedBiosystems, FosterCity,CA)basedon theCtmethod.
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Wound Healing/Scratch and Tube Formation Assay—For
wound healing/scratch assay (32), confluent HUVECmonolayers
were scratched with a standard 20-l pipette tip and incubated in
M199 containing 1% FBS in the presence of recombinant human
VEGF-A (50 ng/ml) (catalog no. 100-20; PeproTech, Rocky Hill,
NJ), TGF1 (5 ng/ml), dynasore (80 M) (catalog no. D7693;
Sigma-Aldrich),ALK5 inhibitor II (2-(3-(6-methylpyridin-2-yl)-1-
H-pyrazol-4-yl)-1,5-naphthyridine) (5 M) (catalog no. 616452;
Merck-CalbioChem), and VEGFR2 inhibitor SU1498 (10 M)
(catalog no. 572888; Merck-Calbiochem) for 8 h. The micropho-
tographs were taken at 0 and 8 h, and the wound width was
determined with ImageJ software. For tube formation assays,
siRNA-transfectedHUVECs (2.0 104 cells) inM199 containing
1% FBS were seeded onto 200 l of growth factor-reduced
Matrigel (BD Biosciences) in a 24-well plate in the absence and
presence of VEGF-A (50 ng/ml), TGF1 (5 ng/ml), dynasore (80
M), ALK5 inhibitor (5 M), and VEGFR2 inhibitor (10 M) and
were incubated for 12 h. Tube formation was quantified bymeas-
uring cumulative tube length in five random microscopic
fields/well using ImageJ software under a BIOREVO microscope
(Keyence, Osaka, Japan).
Matrigel Plug in Vivo Angiogenesis Assay—All of the mice used
in this study were bred andmaintained at the Institute for Exper-
imental Animals, Advanced Science Research Center, Kanazawa
University under specific pathogen-free conditions. All proce-
dures were conducted in accordance with the Fundamental
Guidelines forProperConductofAnimalExperiment andRelated
Activities in Academic Research Institutions under the jurisdic-
tion of the Ministry of Education, Culture, Sports, Science and
Technology of Japan and approved by the Committee on Animal
Experimentation of Kanazawa University. Pik3c2aEC (C2EC)
(Pik3c2aflox/flox; Cdh5(PAC)-CreERT2) and Pik3c2aSMC
(C2SMC) (Pik3c2aflox/flox;SM22a-Cre)miceweredescribedpre-
viously (8). Cre-negative littermateswere used as controls. To ver-
ify the efficiency of Cre recombination, Cremicewerematedwith
mice from the Cre reporter transgenic line ROSA26-LacZ
(B6.129S4-Gt(ROSA)26Sortm1Sor/J, Jackson Lab). All mice had a
C57BL/6J genetic background. For Pik3c2a gene inactivation in
adult mice, tamoxifen (10 mg/ml corn oil) (catalog no. T5648;
Sigma-Aldrich) was administered seven times by intraperitoneal
injection of 100 l of tamoxifen solution. For Matrigel plug assay
(32, 36), recombinant VEGF-A (200 ng/ml), FGF2 (400 ng/ml)
(catalog no. AF-100-18B; PeproTech), and heparin (100 mg/ml)
(Sigma-Aldrich) were mixed with growth factor-reduced Matri-
gel. TheMatrigel solutions (300l each)were injected subcutane-
ously into the groin area close to the dorsal midline (most angio-
genicportion)of anesthetizedmice.Matrigelplugswereharvested
onday 10 and fixedovernight in 4%paraformaldehyde for paraffin
embedding and the following immunohistochemistry.
VEGF-A ELISAAssay—HumanVEGF-A protein levels in the
conditioned medium of HUVEC cultures were determined
using human VEGF-A ELISA immunoassay (catalog no.
DVE00; R&D Systems, Minneapolis, MN) according to the
manufacturer’s protocol. Optical density was measured at 450
nm using a 540-nm correction with a Multiskan GO (Thermo
Fisher Scientific, Walyham, MA).
Statistical Analysis—The data are presented as means S.E.
and expressed as the percentages or multiples relative to the
values in control cells. Statistical significance was analyzed
using Prism 5 software (GraphPad Software Inc., San Diego,
CA). Statistical significance was analyzed either by one-way or
two-way analysis of variance followed by Bonferroni test as
appropriate. Results with p 0.05 were considered statistically
significant.
RESULTS
TGF1-induced Phosphorylation andNuclear Translocation
of Smad2/3 Are Dependent on Class II PI3K-C2—We studied
roles of PI3K isoforms in TGF1-induced Smad2/3 stimulation
in vascular EC. HUVECs were transfected with either of the
specific siRNAs against class I PI3K p110, class II PI3K-C2
and PI3K-C2, and class III Vps34, or scrambled siRNA
(sc-siRNA) as control. Each siRNA effectively inhibited the
expression of respective PI3K proteins but not other PI3K iso-
formproteins (Fig. 1,A andB). In sc-siRNA-transfected control
HUVECs, TGF1 induced a gradual increase in Smad3 phos-
phorylation, which reached the plateau level of an 8-fold
increase over the basal at 30 min (Fig. 1B). Transfection of
PI3K-C2-siRNAs (C2-siRNAs #1 and #2) markedly inhib-
ited TGF1-induced stimulation of Smad3 phosphorylation
throughout the observation time period. TGF1 also induced
Smad2 phosphorylation, which was greatly suppressed by
PI3K-C2 knockdown (Fig. 1C). In contrast, knockdown of
either p110, PI3K-C2, or Vps34 failed to inhibit TGF1-
induced phosphorylation of Smad2/3. TGF1 did not stimulate
phosphorylation of Smad1, Smad5, or Smad8 (Smad1/5/8) in
HUVECs (Fig. 1D). In contrast, BMP9 induced phosphoryla-
tion of Smad1/5/8 (Fig. 1E) but not Smad2/3 (data not shown).
Differently from the case of TGF1, PI3K-C2 knockdown did
not suppress BMP9-induced Smad1/5/8 phosphorylation. In
addition, PI3K-C2 knockdown did not alter TGF1-induced
activation of the noncanonical pathway ERK,which is known to
be independent of Smad2/3 (37), in HUVECs. Similar to
HUVECs, TGF1 stimulated phosphorylation of Smad2/3 in
HMVECs and MLECs in a PI3K-C2-dependent manner (Fig.
2,A and B). TGF1 also stimulated phosphorylation of Smad1/
5/8 in HMVECs, which was also dependent on PI3K-C2 (Fig.
2A). Unlike vascular endothelial cells, deletion of PI3K-C2 in
MASM cells and human colonic epithelial carcinoma Caco2
cells did not inhibit TGF1-induced phosphorylation of
Smad2/3 (Fig. 2, C and D). Thus, PI3K-C2 was necessary for
TGF-induced Smad2/3 phosphorylation in vascular EC but
not in vascular smooth muscle.
Stimulation with TGF1 induced robust nuclear translocation
of Smad2/3 in sc-siRNA-transfected HUVECs as evaluated with
anti-Smad2/3 immunofluorescent staining (Fig. 3A). We also
observed that TGF1 stimulated nuclear accumulation of
p-Smad2, which was also markedly suppressed by PI3K-C2
knockdown (Fig. 3B). In C2-siRNA-transfected HUVECs, the
exogenous expression of the C2-siRNA-resistant form of PI3K-
C2 (C2r) but notwild-type PI3K-C2 (wtC2) restoredTGF-
induced Smad activation (Fig. 3, C and D). In sc-siRNA-
transfected HUVECs, the overexpression of wild-type PI3K-C2
by itself did not change TGF-induced Smad translocation into
the nucleus.Moreover, we determined the effect of the expression
of the kinase-deficient mutant of C2r (kdC2r) on Smad2/3
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FIGURE 1. PI3K-C2 is required for TGF1-induced Smad2/3 phosphorylation in EC. A, siRNA-mediated knockdown of PI3K isoforms. HUVECswere transfected
with PI3K-C2#1 (C2#1)-, PI3K-C2 (C2)-, p110-, Vps34-, and Smad4-specific siRNA or scrambled (sc)-siRNA, and the expression of the PI3K proteins, Smad4, and
-actin as a loadingcontrolwere analyzedwith immunoblotting.Upper panel, representativeblots. Lowerpanel, quantifieddata.B, time-dependentphosphorylation
of Smad3 in response to TGF1 in C2#1, C2#2, or sc-siRNA transfected HUVECs. Serum-starved cells were stimulatedwith TGF1 (5 ng/ml) for the indicated time
periods. The cell lysateswere subjected to immunoblot analysis for p-Smad3 and total Smad2 and Smad3.Upper left panel, effects of siRNA-mediated knockdownof
PI3K-C2. Lower left panel, representativeblotsof Smads.Right panel, quantifieddata.C, effects of knockdownofPI3K isoformsonTGF1-inducedSmad2andSmad3
phosphorylation.HUVECs thathadbeentransfectedwitheitherofC2#1-,C2-, p110-, andVps34-specific siRNAsor sc-siRNAwerestimulatedwithTGF1 (5ng/ml)
for 30min, followedby the immunoblot analysis for p-Smad2, p-Smad3, and total Smad2andSmad3.Upper panel, representativeblots. Lower panel, quantifieddata.
D, time-dependent phosphorylation of Smad1/5/8 in response to TGF1 in HUVECs. The cells were treated as in B. The cell lysates were subjected to immunoblot
analysis for p-Smad1/5/8 and total Smad5. E, time-dependent phosphorylation of Smad1/5/8 in response to BMP9 in HUVECs. Serum-starved cells were stimulated
with BMP9 (10 ng/ml) for the indicated time periods. The cell lysates were subject to immunoblot analysis for p-Smad1/5/8 and total Smad5. In A–E, the data are
means S.E. of three or four determinations (n 3 or 4.). In all figures, the asterisks indicate statistical significance between the indicated groups at the levels of p
0.05 (*), p 0.01 (**), and p 0.001 (***). ns, statistically not significant.
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nuclear translocation. In sc-siRNA-transfected control HUVECs,
the expression of kdC2r inhibited TGF1-induced Smad2/3
nuclear accumulation, differently from wtC2r expression (Fig.
3D). In C2-siRNA-transfected HUVECs, the expression of
kdC2r did not restore TGF1-induced Smad2/3 nuclear accu-
mulation, differently from wtC2r. These observations together
suggest that PI3K-C2 fulfills an indispensable role for TGF1-
induced Smad2/3 activation through its kinase activity in EC.
FIGURE 2. PI3K-C2 is required for TGF-induced Smad2/3 phosphorylation in EC but not smooth muscle cells or epithelial cells. A, TGF1-induced
time-dependent phosphorylation of Smad2/3 and Smad1/5/8 in HMVECs. Serum-starved cells were stimulated with TGF1 (5 ng/ml) for the indicated time
periods. The cell lysateswere subjected to immunoblot analysis for p-Smad1/5/8 andp-Smad2/3.B, effects of Cre-mediateddeletionof C2onTGF1-induced
Smad3 phosphorylation in MLECs. The cells were infected with adenoviruses encoding LacZ (Ad-LacZ) or Cre recombinase (Ad-Cre), stimulated as in A, and
analyzed for p-Smad3. C, effects of Cre-mediated deletion of C2 on TGF1-induced Smad3 phosphorylation in MASM cells. The cells were treated and
analyzed as in A. D, effects of knockdown of PI3K isoforms on TGF1-induced phosphorylation of Smad2/3. Caco2 were treated and analyzed as in A. In A–D,
upper panels indicate representative blots, and lower panels indicate quantified data (n 3–5). The data are expressed as multiples relative to the values in
TGF1-nonstimulated sc-siRNA transfected cells or Ad-Cre-transfected cells.
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FIGURE 3. TGF1-induced nuclear translocation of Smad2/3 depends on PI3K-C2 in EC. A and B, immunofluorescent staining of Smad2/3 (A) and
p-Smad3 (B) in TGF1-stimulated HUVECs. The cells were transfected with C2#1 siRNA or sc-siRNA and stimulated with TGF1 (5 ng/ml) for 30 min,
followed by anti-Smad2/3 antibody or anti-p-Smad3 antibody staining. Nuclei were stained by DAPI. Left panels, representative confocal images of the
stained cells. Right panels, quantified data. The data were obtained from 48 cells per group. Scale bar, 20 m. C, HUVECs were transfected with either
wtC2 or C2-siRNA-resistant C2 (C2r) and either C2#1 siRNA or sc-siRNA. The cells were stimulated with TGF1 (5 ng/ml) for 30 min, followed by
immunoblot analysis for p-Smad3. Left panel, representative blots. Right panel, quantified data (n  3). D, HUVECs were transfected with either
GFP-wtC2, GFP-C2r, or GFP-tagged kinase deficient mutant of C2r (GFP-kdC2r) and either C2-specific siRNA or sc-siRNA. The cells were stimulated
with TGF1 (5 ng/ml) for 30 min, followed by immunofluorescent staining with anti-Smad2/3. Nuclei were stained by DAPI. Scale bar, 20 m. #,
transfected cells.
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TGF1-induced TGF Receptor Internalization into SARA-
containing Endosomes Is Dependent on PI3K-C2—TGF1
stimulation induced an increase in serine phosphorylation of
ALK5 in HEK293T cells transfected with wtALK5 (Fig. 4A). In
HEK293T cells, we observed PI3K-C2 dependence of TGF1-
induced Smad2/3 phosphorylation (data not shown). PI3K-
C2 knockdown did not inhibit TGF-induced serine phos-
phorylation of wtALK5, implying that PI3K-C2 is necessary
for the TGF receptor signaling step, which is distal to phos-
phorylation of type I TGF receptor. Previous studies (28–31)
showed that TGF1 stimulation triggered clathrin-dependent
endocytosis of TGF receptor and that TGF receptor endo-
cytosis was required for TGF activation of Smad2/3 signaling.
We tested the effect of dynasore, an inhibitor of dynamin that is
necessary for clathrin-dependent endocytosis, in EC. Treat-
ment of HUVECs with dynasore abolished TGF1-induced
phosphorylation of Smad2/3, like an ALK inhibitor (Fig. 4B).
Likewise, the expression of the dominant negative dynamin2
mutant but not wild-type dynamin2 inhibited nuclear transloca-
tion of Smad2/3 (Fig. 4C). These observations suggested that
TGF receptor endocytosis was required for Smad2/3 signaling.
TGF1 stimulation promoted the internalization of type I TGF
receptor ALK5 into the intracellular compartment, which was
prevented by PI3K-C2 knockdown (Fig. 5A). Likewise, dynasore
suppressed TGF1-induced ALK5 internalization. In these
immunostainings, the anti-ALK5 antibody stained nuclei. ALK5
knockdown did not abolish or reduce the nuclear staining in anti-
ALK5 immunostaining (Fig. 5B), suggesting that thenuclear stain-
ing was nonspecific. In sc-siRNA-transfected HUVECs, the
expression of kdC2r partially inhibited TGF1-induced ALK5
internalization, differently from that of wtC2r expression (Fig.
5C). In C2-siRNA-transfected HUVECs, the expression of
kdC2r did not restore TGF1-induced ALK5 internalization.
Double immunofluorescent staining of ALK5 and the early endo-
some marker EEA1 showed that TGF1 induced the internaliza-
tion of ALK5 into the EEA1-positive early endosomes (Fig. 5D).
PLA staining to detect interaction or close co-localization of two
molecules showed that TGF1 stimulation induced the close co-
localization of ALK5 and EEA1 (Fig. 5E, green dots), which was
nearly abolished by PI3K-C2 knockdown.
FIGURE 4. TGF signaling requires PI3K-C2 distally to TGF1-induced ALK5 phosphorylation and endocytosis. A, effects of C2 depletion on TGF1-
induced ALK5 phosphorylation. Left panel, representative blots. Right panel, quantified data. HEK293T cells were transfected with either FLAG-wtALK5 or
FLAG-caALK5 and either C2#1 siRNA or sc-siRNA. The cell lysates were immunoprecipitated with anti-Flag antibody, followed by immunoblotting (IB) using
anti-Flag and anti-phosphoserine (p-Ser) antibodies. A portion of the cell lysates was analyzed for the expression of the indicated proteins with IB. IP, immu-
noprecipitation. The data are from three-independent experiments, which yielded comparable results, and are expressed as multiples over the values in
wtALK5 expressed in sc-siRNA-transfected cells. B, effects of the endocytosis inhibitor dynasore and the ALK5 inhibitor (iALK5) on TGF1induced-Smad3
phosphorylation. The cells were prepretreated or notwith dynasore (80M) or ALK5 inhibitor (5M) for 30min and stimulatedwith TGF1 (5 ng/ml) for 30min
(n 5). C, effects of the expression of RFP wild-type dynamin2 (RFP-wtDyn2) or RFP dominant negative dynamin2 (RFP-dnDyn2) on TGF1-induced nuclear
translocation of Smad2/3. The cells were transfectedwith the RFP-wtDyn2 or RFP-dnDyn2 expression vectors and stimulatedwith TGF1 (5 ng/ml) for 30min,
followed by anti-Smad2/3 immunostaining. Nuclei were stained by DAPI. The arrowheads denote the transfected cells. Scale bar, 20 m.
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Because SARA is located in the early endosomes and acts as a
scaffold for Smad2/3 phosphorylation by ALK5 (28–30), we
studied the requirement of SARA for TGF/ALK5 signaling,
the possible co-localization of TGF1 receptors and SARA, and
the effect of PI3K-C2 knockdown on the co-localization.
Knockdown of SARA nearly completely suppressed TGF-in-
duced Smad2/3 phosphorylation (Fig. 6A), indicating that
SARA is essential for TGF/ALK5 signaling in HUVECs. Dou-
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ble immunofluorescent staining using anti-SARA and anti-
EEA1 showed that SARA was localized mainly in the EEA1-
positive early endosome compartment in sc-siRNA-transfected
HUVECs (Fig. 6B). TGF1 increased the SARA- and EEA1-
double positive endosomes. PI3K-C2 knockdown did not
affect the numbers of either SARA-positive or EEA1-positive
vesicles in nonstimulated cells but abolished TGF1-induced
increase in SARA- and EEA1-double positive early endosomes.
PLA staining for ALK5 and SARA, combined with anti-EEA1
immunostaining, showed that TGF1 stimulation induced the
close co-localization of ALK5 and SARA and that a portion of
the closely co-localized ALK5 and SARA existed in the EEA1-
positive early endosomes (Fig. 6C). Knockdown of PI3K-C2
inhibited the close co-localization of ALK5 and SARA in EEA1-
positive early endosomes. These observations indicate that
PI3K-C2 is involved in TGF1-induced ALK5 internalization
into the SARA-containing endosomes through its kinase
activity.
Endosomal Enrichment of PtdIns(3)P and Localization of
SARA Are Not Dependent on PI3K-C2—PI3K-C2 was pre-
viously reported to generate PtdIns(3)P and PtdIns(3,4)P2 in
vivo (8, 12–14). Because SARA is localized in early endo-
somes by binding PtdIns(3)P through its FYVE domain, we
studied the effects of knockdown of PI3K-C2 and other
PtdIns(3)P-producing PI3K on the cellular level and local-
ization of PtdIns(3)P and PtdIns(3,4)P2 by observing GFP
fluorescence of HUVECs that had been transfected with
the expression vectors for the PtdIns(3)P-specific probe
GFP-FYVESARA or the PtdIns(3,4)P2-specific probe GFP-
PHTAPP1. In sc-siRNA-transfected nonstimulated HUVECs,
the GFP-FYVESARA signal was a punctate pattern as reported
previously in nonendothelial cells (29) (Fig. 7A), suggesting that
PtdIns(3)P was enriched in endosomes. TGF1 stimulation did
not change GFP-FYVESARA signal. Among three PI3Ks, knock-
down of PI3K-C2 did not affect GFP-FYVESARA signal. In
contrast, that of either PI3K-C2 or Vps34 obviously reduced
the density of vesicular GFP-FYVESARA signals. Consistent
with these observations, knockdown of either PI3K-C2 or
Vps34 reduced anti-SARA-positive endosomes unlike PI3K-
C2 knockdown and augmented the diffuse cytosolic anti-
SARA staining (Fig. 7B), suggesting that PI3K-C2 and Vps34
but not PI3K-C2 generate PtdIns(3)P in SARA-containing
endosomes. Thus, PI3K-C2 seems to participate in TGF-
induced signaling, without altering the endosomal distribution
of SARA.
In contrast to the effects on PtdIns(3)P level, TGF1 induced
a rapid increase in GFP-PHTAPP1 signal in lamellipodia (Fig. 7C
and supplemental Movies S1 and S2), suggesting a localized
increase in the membrane PtdIns(3,4)P2 level in TGF1-stim-
ulated cells. Notably, PI3K-C2 knockdown abolished TGF1-
induced increase in GFP-PHTAPP1 signals, indicating that
PI3K-C2 is involved in the generation of PtdIns(3,4)P2 in
lamellipodia. The recent study implicated PI3K-C2-generated
PtdIns(3,4)P2 in endocytosis (14). Therefore, it is an interesting
possibility that PI3K-C2 is involved in TGF1-induced endo-
cytosis of TGF receptor through forming PtdIns(3,4)P2 in the
plasma membrane.
PI3K-C2 Is Required for SARA-Smad2/3 Complex Formation—
BecauseSARA is associatedwithSmad2/3 andacts as a scaffold for
Smad2/3 phosphorylation by type I TGF receptor ALK5, we
studied the PI3K-C2 dependence of SARA-Smad2/3 complex
formation, using anti-SARA immunoprecipitation and the follow-
ing anti-Smad2/3 immunoblotting. For the experiments, we
employed HEK293T cells for efficiency of gene transduction. We
co-transfected HEK293T cells with the expression vectors for
either wtSARA or the SBD-SARA and either wtALK5 or
caALK5, with or without Smad2/3 expression vectors. We
detected co-immunoprecipitation of Smad2/3 in the anti-SARA
immunoprecipitates in the cells transfected with Smad2/3,
wtSARA, and wtALK5. However, without Smad2/3 transfection,
we did not detect Smad2/3 in the anti-SARA immunoprecipitates
(Fig. 8A). In sc-siRNA-treated control cells that had been trans-
fected with wtSARA and wtALK5, we detected the association of
Smad3 and Smad2with SARA (Fig. 8,B andC). The expression of
caALK5 substantially stimulated the association of Smad3 and
Smad2 with SARA and resultant phosphorylation of Smad3 and
Smad2, which were both markedly inhibited by the expression of
SBD-SARA. In contrast, in PI3K-C2-depleted cells, caALK5
expression barely stimulated the association of Smad3 and Smad2
with SARA and phosphorylation of Smad3 and Smad2. Thus,
PI3K-C2 is required for ALK5-mediated formation of the SARA
and Smad2/3 complex and phosphorylation of Smad2/3.
We also studied the interaction of endogenous SARA and
Smad2/3 in HUVECs using PLA staining. TGF1 promoted
SARA-smad2/3 interaction in the endosomes in sc-siRNA-
transfected control HUVECs. A portion of the PLA signal was
co-localized with EEA1, indicating that SARA and Smad2/3 com-
plex were located in the early endosomes. PI3K-C2 knockdown
inhibited TGF1-stimulated SARA-smad2/3 interaction (Fig.
8D). The observations indicate that TGF1 stimulation of the
FIGURE 5. PI3K-C2 is required for TGF1-induced internalization of TGF receptor into the early endosomes in EC. A, effects of C2 depletion or
dynasore on TGF1-induced internalization of endogenous ALK5. The cells were either transfected with C2#1 siRNA or sc-siRNA or pretreated with
dynasore (80 M) for 30 min and stimulated with TGF1 (5 ng/ml) for 30 min. Left panel, representative confocal images of the stained cells. Right panel,
quantified data of fluorescence intensity per cell that were obtained from 24 cells per group. Nuclei were stained by DAPI. Scale bar, 20 m. B, effects of
ALK5 knockdown on the nuclear staining in anti-ALK5 immunostaining. HUVECs were transfected with ALK5-specific siRNA (ALK5-siRNA) or sc-siRNA,
followed by anti-ALK5 immunofluorescent staining. Nuclei were stained by DAPI. Scale bar, 20 m. #, nonspecific nuclear signals. C, effects of the
expression of a kinase-deficient C2mutant on TGF1-induced ALK5 internalization. HUVECs were transfected with either GFP-C2r or GFP-kdC2r and
either C2#1 siRNA or sc-siRNA. The cells were stimulated with TGF1 (5 ng/ml) for 30 min, followed by immunofluorescent staining with anti-ALK5
antibody. Nuclei were stained by DAPI. #, transfected cells. D, double immunofluorescent staining of ALK5 (green) and EEA1 (red) in TGF1-stimulated
HUVECs. The cells were transfected with C2#1 siRNA or sc-siRNA and stimulated with TGF1 (5 ng/ml) for 30 min. Left panel, representative confocal
images of the stained cells. Magnified views of the boxed areas are also shown. Nuclei were stained by DAPI. Scale bar, 20m. Right panel, quantified data
of the ALK5/EEA1-double positive vesicle numbers per cell that were obtained from 24 cells per group. E, PLA staining of ALK5 and EEA1 (green) in
TGF1-stimulated HUVECs. The cells were transfected with C2#1 siRNA or sc-siRNA and stimulated with TGF1 (5 ng/ml) for 30 min. Nuclei were
stained by DAPI. Upper panel, representative confocal images of the stained cells. Scale bar, 20 m. Lower panel, quantified data of the numbers of
ALK5/EEA1 interactions per cell that were obtained from 24 cells per group.
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interaction of endogenous SARA and Smad2/3 in the endosomes
requires PI3K-C2 in HUVECs.
PI3K-C2 Is Required for TGF1-induced VEGF-A Expres-
sion in EC—Consistent with previous studies (38–41), TGF1
increased the expression of mRNA and protein of VEGF-A in
control HUVECs (Fig. 9, A–C). The stimulatory effects of
TGF1 were inhibited by knockdown of the common Smad
Smad4, suggesting the involvement of Smad2/3. Furthermore,
TGF1-induced VEGF-A expression was abolished by the
pharmacological blockade of ALK5 (Fig. 9D). These observa-
tions together suggested that TGF1-inducedVEGF-Aup-reg-
ulation was dependent on the ALK5-Smad pathway. In agree-
ment with the involvement of the canonical Smad pathway in
TGF1-induced VEGF-A expression, knockdown of PI3K-
C2, but not PI3K-C2, p110, or Vps34, inhibited TGF1-
induced VEGF-A expression (Fig. 9, A–C). Moreover, treat-
FIGURE6.PI3K-C2 is required for TGF receptor internalization intoSARA-containingendosomes inEC.A, effects of SARAdepletiononTGF1-induced
Smad2/3 phosphorylation in HUVECs. The cells were transfected with SARA-specific siRNA or sc-siRNA. Serum-starved cells were stimulated with TGF1 (5
ng/ml) for the indicated time periods and subjected to immunoblot analysis for p-Smad2, p-Smad3, and total Smad2 and Smad3. Left panel, representative
blots. Right panel, quantified data (n 3). B, double immunofluorescent staining of EEA1 (red) and SARA (green) in TGF1-stimulated HUVECs. The cells were
transfected with C2#1 siRNA or sc-siRNA and stimulated with TGF1 (5 ng/ml) for 30 min. Nuclei were stained by DAPI. Right panel, quantified data of the
numbers of SARA (upper panel), EEA1 (middle panel), andSARA/EEA1-double (lower panel) positive vesicle numbersper cell thatwereobtained from48cells per
group. Scale bar, 20m.C, PLA staining (green) of ALK5 and SARAand anti-EEA1 immunostaining (red) in TGF1-stimulatedHUVECs. The cellswere transfected
with C2#1 siRNA or sc-siRNA and stimulated with TGF1 (5 ng/ml) for 30 min. Left panel, representative confocal images of the stained cells. Green and red
denote PLA signals and immunostaining signals, respectively. Nucleiwere stainedbyDAPI. Scale bar, 20m.Right panel, quantifieddata of thenumbers of PLA
signals (left graph) and PLA signal/anti-EEA1-double positive vesicle numbers per cell (right graph) that were obtained from 24 cells per group.
FIGURE 7. PI3K-C2 is not required for PtdIns(3)P enrichment or the localization of SARA in the endosomes but for TGF-induced increase in
PtdIns(3,4)P2 in lamellipodia. A, GFP-FYVESARA fluorescence. The HUVECs were co-transfected with the GFP-FYVESARA expression vector and either C2#1
siRNAs or sc-siRNA and stimulated with TGF1 (5 ng/ml) for 30 min or left untreated. Nuclei were stained by DAPI. Left panel, representative confocal images.
Right panel, quantified data of the numbers of GFP-FYVE fluorescence-positive vesicles per cell that were obtained from 48 cells per group. B, anti-SARA
immunofluorescent staining. The HUVECs were transfected with either C2-siRNAs or sc-siRNA and stimulated with TGF1 (5 ng/ml) for 30 min or left
untreated. Nucleiwere stainedbyDAPI. Left panel, representative confocal images.Right panel, quantified data of anti-SARA-positive vesicles per cell thatwere
obtained from 48 cells per group. Scale bar, 20m. C, GFP-PHTAPP1 fluorescence. The HUVECswere co-transfectedwith the GFP-PHTAPP1 expression vector and
either C2-siRNAs or sc-siRNA and stimulated with TGF1 (5 ng/ml) for 30 min or left untreated. Nuclei were stained by DAPI. Confocal images at 2, 5, and 10
min after the additions of TGF1 or vehicle are shown.
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FIGURE 8. SARA-Smad3 complex formation is dependent on PI3K-C2. A–C, analyses of complex formation between SARA and Smad2/3 by co-
immunoprecipitation-immunoblotting in HEK293T cells. A, the cells were transfected with the expression vectors for either wtSARA or SBD-SARA and
either wtALK5 or caALK5, with or without Smad2/3 expression vectors. The cell lysates were immunoprecipitated with anti-SARA antibody, followed by
immunoblotting (IB) using anti-SARA, anti-Smad3, or anti-Smad2 antibody. B and C, the cells were co-transfected with the expression vectors for either
Smad2 or Smad3, either wtSARA orSBD-SARA, either wtALK5 or caALK5, and either C2#1 siRNA or sc-siRNA. The cell lysates were immunoprecipitated
with anti-SARA antibody, followed by immunoblotting using anti-SARA, anti-Smad3 antibody in B, and anti-Smad2 antibody in C. Portions of the cell
lysates were analyzed for the expression of the indicated proteins with immunoblotting (Input). IP, immunoprecipitation; Ctrl, control. Left panel,
representative blots. Right panel, quantified data of the amounts of Smad3 and Smad2 in immunoprecipitates from the cells transfected as indicated.
The data aremeans S.E. from four independent experiments, which yielded comparable results, and expressed asmultiples over the values in wtALK5-
and sc-siRNA-transfected cells.D, PLA staining of SARA and Smad2/3 (green) and anti-EEA1 immunostaining (red) in TGF1-stimulated HUVECs. The cells
were transfectedwith C2#1 siRNA or sc-siRNA and stimulatedwith TGF1 (5 ng/ml) for 30min. Left panel, representative confocal images of the stained
cells. Green and red denote PLA signals and immunostaining signals, respectively. Nuclei were stained by DAPI. Scale bar, 20 m. Right panel, quantified
data of the numbers of PLA signals (left graph) and PLA signal/anti-EEA1 staining-double positive vesicle numbers per cell (right graph) that were
obtained from 24 cells per group.
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ment of HUVECs with dynasore abolished TGF1-induced
VEGF-A mRNA expression with suppression of Smad3 phos-
phorylation (Figs. 4B and 9C). These findings indicate that
PI3K-C2- and endocytosis-dependent Smad2/3 signaling
mediates TGF-induced VEGF-A expression in EC.
PI3K-C2 Is Required for TGF1-induced Endothelial Cell
Migration, Tube Formation, and in Vivo Angiogenesis—In a
wound healing assay, PI3K-C2 knockdown inhibited migra-
tion of HUVECs induced by either TGF1 or VEGF-A (Fig. 10,
A and B). The ALK5 inhibitor suppressed TGF1-induced cell
migration. Interestingly, the inhibitor of VEGFR2 suppressed
not only VEGF-induced but also TGF1-induced cell migra-
tion, indicating that TGF1-induced cell migration is depen-
dent on VEGFR2. Likewise, PI3K-C2 knockdown inhibited
tube formation induced by either TGF1 or VEGF-A (Fig. 10,C
and D). The inhibition of VEGF-A-induced tube formation by
PI3K-C2 knockdown ismost likely becauseVEGFR2 signaling
is dependent on PI3K-C2 as we demonstrated previously (8).
The ALK5 inhibitor and the VEGFR2 inhibitor blocked
TGF1-induced tube formation (Fig. 10, E and F). In addition,
dynasore suppressed TGF1-induced tube formation. These
observations suggest that TGF1-induced, ALK5-mediated
stimulation of endothelial migration and morphogenesis is
dependent on stimulation of VEGF-A expression and VEGFR2
signaling, in which PI3K-C2 and the endocytic process are
involved.
We finally investigated a role for PI3K-C2 in in vivo angio-
genesis, using a Matrigel plug assay in conditional PI3K-C2
knock-out mice. We subcutaneously injected Matrigel plug
with or without TGF1 in mice with endothelial specific dele-
tion of PI3K-C2 (C2EC) or smooth muscle-specific PI3K-
C2 deletion (C2SMC) and compared angiogenesis in both
mutant mice with that in control mice (C2flox/flox). The inclu-
sion of TGF1 in Matrigel increased the formation of anti-
vWF-positive microvessels in Matrigel plugs in control mice,
compared with vehicle (Fig. 11, A–F). In contrast, in C2EC
mice TGF1 failed to stimulate microvessel formation. In
C2SMC mice, however, TGF1 stimulated microvessel for-
mation inMatrigel plugs to the similar extent as in controlmice
(Fig. 11, D–F). We performed double immunofluorescent
staining of p-Smad2 andECmarkerCD31 inMatrigels contain-
ing either TGF or vehicle that had been implanted in C2aDEC
FIGURE 9. PI3K-C2 is required for TGF1-induced, Smad-dependent VEGF-A production in EC. HUVECs were transfected with either of C2(#1), C2,
p110, Vps34, and Smad4-specific siRNA or sc-siRNA and stimulated with TGF1 in the presence and absence of the indicated inhibitors. A, VEGF-A (VEGFA)
mRNA expression in the cells stimulated with TGF1 (5 ng/ml) for 6 h. The VEGFA mRNA expression levels were determined with real time PCR and were
corrected for 18 S rRNA level (n 6). B, VEGFAmRNA expression in the cells were transfected with either of C2#1, C2#2, and sc-siRNA and stimulated with
TGF1 (5 ng/ml) for 6 h. The VEGFA mRNA expression levels were determined with real time PCR and were corrected for 18 S rRNA level (n 3). C, VEGF-A
peptide concentrations in the media of the cells stimulated with TGF1 (5 ng/ml) for 12 h (n 3). D, effects of dynasore and ALK5 inhibitor on VEGFA mRNA
expression. The cells were prepretreated or not with dynasore (80 M) or iALK5 (5 M) for 30 min and stimulated with TGF1 (5 ng/ml) for 6 h (n 5). In A–D,
the data are expressed as multiples over the values in TGF1-nonstimulated sc-siRNA-transfected or vehicle-treated control cells.
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and C2aDSMC mice. C2aDEC mice showed much reduced
p-Smad2- and CD31-double positive cells compared with
C2aDSMC (Fig. 11G), suggesting that Smad2 activation in EC
was attenuated in C2aDEC mice. These observations suggest
thatTGF1-inducedmicrovessel formation inMatrigel plugs is
dependent on PI3K-C2 that is expressed in ECbut not smooth
muscle.
DISCUSSION
Accumulated evidence indicates that TGF receptor-Smad2/3
signaling is dependent on the endocytosis of the TGF receptor
complex (28–31).UponTGFbinding,TGF receptors are inter-
nalized into early endosomes, where the Smad anchor SARA is
enriched through its FYVE domain. SARA interacts with
Smad2/3, facilitating Smad2/3 phosphorylation and thereby their
nuclear translocation. PI3Kmaybe involved in at least two stepsof
these TGF receptor signaling processes: TGF-induced TGF
receptor internalization and the endosomal localization of SARA.
In the present study, we identified class II PI3K-C2 as PI3K iso-
form that is engaged in TGF-induced activation of Smad2/3 sig-
naling. Our data indicate that PI3K-C2 is required for the endo-
cytosis of TGF receptor but not for endosomal localization of
SARA.
The present observation in EC that TGF-induced Smad2/3
phosphorylation is dependent on TGF receptor internaliza-
tion into the EEA1-positive, SARA-containing early endo-
somes (Figs. 4–6) is similar to the previous observations in
other types of cells including HeLa cells, HepG2 cells, and
Mv1Lu cells (28, 30, 31), although some discrepant results on
the necessity of SARA for ALK5/Smad2/3 signaling were
reported (42, 43). Either PI3K-C2 depletion (8090%) or
the expression of the kinase-deficient Cmutant strongly sup-
FIGURE 10. TGF1-induced endothelial cell migration and tube formation are VEGFR2-mediated and PI3K-C2-dependent. A and B, effects of
inhibitors of VEGFR2 and ALK5 on TGF1- and VEGF-induced cell migration. HUVECs were stimulated with TGF1 (5 ng/ml) or VEGF (50 ng/ml) in the
presence and absence of iALK5 (5M) and the VEGFR2 inhibitor (iVEGFR2) (10M). Cell migration was determined with scratch wounding healing assay.
A, representative microscopic views. B, quantified data (n  4). C and D, effects of C2-knockdown on TGF1- and VEGF-induced tube formation.
siRNA-transfected cells were stimulated with VEGF-A (50 ng/ml) or TGF1 (5 ng/ml) for 12 h. C, representativemicroscopic views;D, quantified data (n
4). E and F, effects of dynasore (80 M), iVEGFR2 (10 M), and iALK5 (5 M) on TGF1- and VEGF-induced tube formation. E, representative microscopic
views. F, quantified data (n  4).
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pressed the internalization of TGF receptor, like the dynamin
inhibitor dynasore (Fig. 5). Because either PI3K-C2 depletion
or dynasore markedly inhibited TGF-induced Smad2/3 phos-
phorylation (Figs. 1, B and C, and 4B), there is a good correla-
tion between TGF-induced TGF receptor internalization
and Smad2/3 phosphorylation. As discussed in detail below,
PI3K-C2 depletion did not compromise the endosomal distri-
bution of the Smad anchor SARA. Based on these findings, it is
reasonable to suggest that PI3K-C2 is involved in TGF
receptor-activated Smad2/3 signaling largely through regulat-
FIGURE 11. Endothelial PI3K-C2 is necessary for TGF1-induced angiogenesis in vivo.Matrigels containing PBS (vehicle) or TGF1were injected into the
subcutaneous tissues on theback of EC-specific C2-deleted (C2EC), SMC-specific C2-deleted (C2SMC), and control (C2flox/flox)mice.Matrigel plugswere
removed10days later andanalyzed formicrovascular formationby immunohistochemistryusinganti-vWFantibody.AandD, representative viewsof anti-vWF
immunostained sections of Matrigel plugs in C2EC (A) and C2SMC (D) mice. B and E, quantified data of neovessel formation in Matrigel plugs (seven mice
per group).C and F, representative gross views ofMatrigel plugs resected frommice.G, double immunofluorescent staining of CD31 (red) andp-Smad2 (green)
in Matrigel plugs in C2EC (left panel) and C2SMC (right panel) mice. Nuclei were stained by DAPI. Scale bar, 50 m.
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ing TGF receptor internalization. In addition, the overexpres-
sion ofwtC2 did not affect TGF-induced Smad2/3 activation
or ALK5 internalization, suggesting that the endogenous level
of wtC2 was sufficient for full activation of TGF receptor-
induced Smad2/3 signaling.
We recently demonstrated in EC that ligand binding-trig-
gered endocytosis of two different classes of cell surface recep-
tors, VEGFR2 and S1P1, was dependent on PI3K-C2 (8, 15).
Interestingly, PI3K-C2 depletion inhibited only a part of mul-
tiple signaling pathways activated by VEGF and S1P: Rho acti-
vation in VEGF signaling and Rac activation in S1P signaling.
We observed using FRET imaging technique that both VEGF-
induced Rho activation and S1P-induced Rac activation
occurred in PtdIns(3)P-enriched endosomes, as well as the
plasma membrane. The present study together with those pre-
vious observations indicate that PI3K-C2 participates in sig-
naling on the endosomes, upon the activation of different
classes of receptors including receptor tyrosine kinases, G pro-
tein-coupled receptors, and receptor serine/threonine kinases.
Thus, the ability of PI3K-C2 to regulate the endocytosis of
different classes of cell surface receptors controls endosomal
signaling.
A recent study (14) suggested a novel mechanism about a gen-
eral role of PI3K-C2 in clathrin-dependent endocytosis in non-
vascular cells; the formation of PtdIns(3,4)P2 by PI3K-C2 at
clathrin-coated pits and late endocytic intermediates before
dynamin-mediated fission recruited the PtdIns(3,4)P2–effector
protein SNX9, promoting maturation of clathrin-coated pits
toward endocytic vesicles. They suggested that PI3K-C2 formed
PtdIns(3,4)P2 from PtdIns(4)P, which was generated through
5-dephosphorylation of PtdIns(4,5)P2 enriched in the clathrin-
coated pits. We observed that TGF1 induced the rapid and sus-
tained formationof lamellipodiawitha local lamellipodial increase
inPtdIns(3,4)P2 (Fig. 7C). In the lamellipodial regionof theplasma
membrane, endocytosis carries membrane-anchored Rho
GTPases and integrins to the cell interior, and thesemolecules are
recycled to the specific regions of the plasma membrane, which
promotes lamellipodial protrusion (44). Considering the rapid
onset of TGF1-induced lamellipodial formation and an increase
in PtdIns(3,4)P2 level, these responses very likely represent non-
genomic effects of TGF1. It remains to be clarified how TGF
induces a rapid increase in the level of PtdIns(3,4)P2 through a
mechanism involving PI3K-C2 in EC.
The interaction of the FYVE domain in SARA with
PtdIns(3)P, a predominant phosphoinositide in the endosomes,
serves the endosomal localization of SARA (28, 29, 45). Previ-
ous studies (12, 46) showed that PI3K-C2 formed PtdIns(3)P
in cells. These observations together with the finding of the
endosomal localization of PI3K-C2 (8) suggested that PI3K-
C2 might be responsible for enrichment of PtdIns(3)P in the
endosomes. However, the present study showed that PI3K-C2
depletion did not reduce PtdIns(3)-enriched endosomes (Fig.
7A). Instead, knockdown of either PI3K-C2 or Vps34 reduced
PtdIns(3)-enriched endosomes. In agreement with these find-
ings, knockdown of PI3K-C2 or Vps34 but not PI3K-C2
reduced SARA-containing vesicles (Fig. 7B). Our observations
of the effects of PI3K-C2 and Vps34 depletion on SARA dis-
tribution are consistent with the previous reports showing that
the nonselective PI3K inhibitor wortmannin totally changed
the endosomal localization of SARA to a diffuse cytosolic pat-
tern with inhibition of Smad signaling at the relatively low con-
centrations of 50–100 nM (29, 45). This range of concentration
of wortmannin does not effectively inhibit PI3K-C2 because
PI3K-C2 is relatively resistant to wortmannin compared with
the other PI3K (5, 7, 47). Thus, PI3K-C2 is not amajor enzyme
to be responsible for the accumulation of PtdIns(3)P in the
SARA-localized vesicular compartment. Our data indicate that
the other PI3K including class II PI3K-C2 and class III Vps34
are involved in PtdIns(3)P accumulation in this compartment.
Another point of interest is that partial reductions (2530%) of
SARA association with the endosomes by depletion of either
PI3K-C2 or Vps34 (Fig. 7B) did not inhibit Smad2/3 phos-
phorylation (Fig. 1C), which suggests that such partial reduc-
tions of the SARA association with the endosomes do not com-
promise Smad signaling.
We observed that PI3K-C2 depletion suppressed TGF-
induced Smad2/3 signaling in several different vascular EC of
human and mouse origins, but not vascular smooth muscle or
epithelial cells (Figs. 1 and 2). In addition, Smad2/3 phosphor-
ylation mediated by caALK5 in HEK293 cells was also PI3K-
C2-dependent (Fig. 8). Therefore, there appears to be some
cell type specificity concerning the PI3K-C2 dependence. A
few explanations for this may be possible. Another class II PI3K
member, PI3K-C2, possesses the similarities to PI3K-C2, in
the distribution of the expression, the structure, the clathrin
binding capacity, and the substrate specificity (7). Functionally,
PI3K-C2 is necessary for growth factor signaling (48) and cell
migration with its lamellipodial distribution (49). Therefore, in
vascular smooth muscle cells and epithelial cells, PI3K-C2
may be able to compensate for PI3K-C2 depletion. Alterna-
tively, it might be possible that TGF-induced Smad2/3 signal-
ing could be cell type-specific, because it was reported that the
dependence of Smad2/3 signaling on endocytosis differed,
depending on cell type (50).
In EC, TGF-induced activation of Smad2/3 signaling path-
way is linked to the up-regulation of VEGF-A gene expression
(39, 41). Consistent with the essential role of PI3K-C2 in
TGF-induced Smad signaling activation, TGF stimulation of
VEGF-A expression was completely and specifically dependent
on PI3K-C2 (Fig. 9). Interestingly, TGF-induced endothelial
cell migration and tube formation were both dependent on
VEGFR2 (Fig. 10). It is reasonable to conceive that VEGF-A-
stimulated cell migration and tube formation requires PI3K-C2
because VEGFR2 signaling and transport of VE-cadherin and
other molecules are dependent on vesicular trafficking (8, 51).
Hence, TGF-induced stimulation of these cellular responses
requires PI3K-C2 for at least at two steps, i.e. TGF-induced
Smad2/3 signaling-dependent VEGF expression and VEGF acti-
vation of VEGFR2 signaling. PI3K-C2 has a significant in vivo
functional role inTGF-inducedneovessel formationat anorgan-
ismal level as demonstrated by the observations in EC-specific
PI3K-C2-deletedmice (Fig. 12).
Previous studies showed that TGF stimulated proliferation
andmigration of ECs via ALK1, whereas TGF inhibited prolifer-
ation andmigrationofECs viaALK5 (24, 52), although some stud-
ies (41, 53) showed thatALK5-mediated stimulation of cellmigra-
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tion. The present observations suggest that ALK5-mediated
stimulation of EC migration involves an indirect mechanism, i.e.
stimulation by autocrine/paracrine VEGF. TGF-induced phos-
phorylation of Smad1/5/8was dependent on PI3K-C2, as well as
Smad2/3 phosphorylation (Fig. 2A). It is intriguing to see how
ALK1-mediated Smad1/5/8 phosphorylation is dependent on
PI3K-C2 in a future study.
In summary, the present study indicates that PI3K-C2 is
indispensable for TGF-induced Smad signaling through being
engaged in the internalization of TGF receptors into the Smad
anchor SARA-containing early endosomes. Thus, our study
suggests that PI3K-C2 is essential for endosomal signaling of
TGF receptors. The elucidation of the role for PI3K-C2 in
TGF receptor signaling opens the new avenue for understand-
ing in more depth normal TGF actions and their derange-
ments in diseases.
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